Drugs / AZD1446
last change Mar 2011 re-read 2 minutes ago

AZD1446

also known as AZD1446 HCL · TC-6683 · TC6683 HCL

Small molecule

Developed for
Alzheimer disease · attention deficit-hyperactivity disorder
Investigated by
AstraZeneca

Trials 11 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 18 trials
Phase 1 NCT01199315 Sep → Dec 2010 AstraZeneca Completed No outcome recorded
Phase 1 NCT01092299 Feb → Jul 2010 AstraZeneca Completed No outcome recorded
Phase 1 NCT01021189 Dec 2009 → Jun 2010 AstraZeneca Completed No outcome recorded
Phase 1 NCT01044342 Dec 2009 → Apr 2010 AstraZeneca Completed No outcome recorded
Phase 1 NCT00997308 Oct → Dec 2009 AstraZeneca Completed No outcome recorded
Phase 1 NCT00902993 Apr → Sep 2009 AstraZeneca Completed No outcome recorded
Phase 1 NCT00886067 Apr → Aug 2009 AstraZeneca Completed No outcome recorded
Phase 1 NCT00803855 Dec 2008 → Apr 2009 AstraZeneca Completed No outcome recorded
Phase 23 trials
Phase 2 NCT01125683 Jun 2010 → Mar 2011 Alzheimer disease AstraZeneca Terminated No outcome recorded
Phase 2 NCT01039701 Dec 2009 → Jul 2010 AstraZeneca Completed No outcome recorded
Phase 2 NCT01012375 Nov 2009 → Aug 2010 attention deficit-hyperactivity disorder AstraZeneca Completed No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 12 sources stand behind the page.

FieldValueCited text
Known as AZD1446 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01039701
10

NCT01044342

NCT01125683

NCT01092299

NCT00902993

NCT00803855

NCT01199315

NCT01021189

NCT00886067

NCT00997308

NCT01012375

Known as AZD1446 HCL ChEMBL registry synonym — accepted as the source's own label CHEMBL2179529
Known as TC-6683 ChEMBL registry synonym — accepted as the source's own label CHEMBL2179529
Known as TC6683 HCL ChEMBL registry synonym — accepted as the source's own label CHEMBL2179529
Modality Small molecule CHEMBL2179529
Route Oral oral, single dose” NCT00803855